This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Sep. 20, 2013

Home   About   Meetings   News   Membership   Gallery   Contact

 


Western Section AUA NEWS YOU NEED NOW

Attention Young Urologists! — Attend the Young Urologist Forum at the Western Section's Annual Meeting in Monterey Monday, Nov. 4 at 5 p.m.!
WSAUA
Department Heads — send this to the Young Urologists in your division.

Program:
Meet & Greet Reception and Featured Speaker: Christopher J. Kane MD, FACS, Professor and Interim Chair, Department of Surgery Chair, Department of Urology, UCSD
Speaking on: Facing an Uncertain Health Care Market: A View from the Trenches for Young Urologists
Be sure to attend this important forum, RSVP to info@wsaua.og - mention YU Forum in email.

Biography:
Christopher Kane, MD, professor of surgery, is Chair of the Department of Urology, and leader of the genitourinary oncology team at UC San Diego Moores Cancer Center. Dr. Kane is an internationally recognized expert in robot-assisted prostatectomy, open and laparoscopic kidney cancer surgery, and bladder and testes cancer surgery.

Dr. Kane has taught laparoscopy and robotic surgery extensively and started the robotic surgery programs at numerous medical centers. Prior to his arrival at UC San Diego Health System, he held leadership positions at the UC San Francisco and the Naval Medical Center San Diego.

Dr. Kane completed his urology residency at UC San Francisco and Oakland Naval Hospital. He earned his medical degree at Uniformed Services University and his bachelor’s degree in mechanical engineering at UC Davis. His numerous military honors include the Navy Commendation Medal, the Combat Action Ribbon and the Humanitarian Service Medal.

Dr. Kane has authored more than 230 publications and book chapters, primarily on prostate cancer risk factors and outcomes, prostate cancer surgery, and minimally invasive surgery for prostate and kidney cancer. He is on the editorial board of a number of major urology journals and he currently is on the NCCN prostate cancer guidelines committee and co-chairs the National Cancer Institute task force on kidney cancer.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Announcing The Inaugural Western Section Residents Bowl!
For the first time, the WSAUA will start a new tradition of hosting a Residents Bowl at the annual meetings. Each training institution was already sent an invitation to be represented by one resident who can participate. There will be mixed teams of four residents and the final winning team will represent the Western Section at the AUA's Annual Meeting Resident Bowl in Orlando next year. Will you participate?

Game Schedule (all taking place in exhibit hall)
Round 1: 2:40-3 p.m. Nov. 5
Round 2: 6:30-7 p.m. Nov. 5
Round 3: 9:30-10 a.m. Nov. 6 (Finals)

Residents Bowl Participants as of Sept. 19!
Dr. William Chu - Kaiser Perm., Los Angeles
Dr. Roger Li - Loma Linda
Dr. Mark Tyson - Mayo Clinic Arizona
Dr. Brian Cox - SMU
Dr. Aviva Weinberg - Standford
Dr. Nishant Patel - UC San Diego
Dr. Renea Sturm - UC Davis
Dr. Reza Hamidizadeh - Univ. of BC
Dr. Franklin Lee - Univ. of WA
Dr. Brock O'Neil - Univ. of UT

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Special Offer for WSAUA members — Practice Review
Are you concerned about diminishing reimbursements? Time to take action and give your practice a check up!
1) Take advantage of the complimentary Practice Analysis.
2) See how you can prepare for the Affordable care Act.
From production and reimbursement to coding and A/R, find out where you are and what you can do to take advantage of the changes in healthcare and to protect your practice.
 


ATTENTION RESIDENTS
Attend the Resident's Luncheon & Program during WSAUA Annual Meeting

Surviving After Residency
Learning the Business Side of Practice
Sunday, Nov. 3, 11:15 a.m. – 1:15 p.m.

Presented by: Dr. Jonathan Perley, Harbor UCLA Medical Center, Dr. Mark Edney, MD, AUA Galagher Health Policy Scholar, Peninsula Urology Assoc., Maryland, Dr. Eugene Y. Rhee, AUA Galagher Health Policy Scholar, Kaiser San Diego and Dr. David Y. Josephson, Tower Urology Los Angeles

Topics include: How to decide on the right job, Insurance, reimbursement and coding, The economic landscape and how it relates to medicine today, panel discussion with academic and Kaiser Faculty Medical and surgical management of OAB urology patients, Health policy/AUA guidelines and growth strategies involving young urologists. RSVP to info@wsaua.org to attend.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


More Experts Take The Stage At WSAUA's Monterey Meeting
Just Added! State of the Art Lecture: Thursday 11/7 Prostate II Session
New Treatments for Advanced Prostate Cancer presented by Fred Millard, MD.

Just Added!
State of the Art Lecture: Tuesday 11/5 Prostate I Session

State of the Art Lecture presented by: Sean Stroup, MD, Naval Med. Ctr. San Diego, speaking on "Fluorescent Imaging for Lymph Node Mapping.

Just Added!
Young Urologist Forum Monday 11/4 5 -6:30 P.M
. featuring:
Christopher Kane, MD, Chairman, UCSD Dpt. of Urology & Interim Chair, UCSD, Dpt. of Surgery to presenting "Facing an Uncertain Health Care Market: A View from the Trenches for Young Urologists."

For more on the program and speaker lineup read more here.



IMPORTANT WESTERN SECTION DATES

Date Event
Sept. 20 Hotel Reservations — Sellout Expected
Oct. 17 Pre-Registration Deadline


TOP STORIES


The Validity of the Distress Thermometer in Prostate Cancer Populations
MD Linx
The Distress Thermometer (DT) is widely recommended for screening for distress after cancer. However, the validity of the DT in men with prostate cancer and over differing time points from diagnosis has not been well examined. The DT is a valid tool to detect cancer–specific distress, anxiety and depression among prostate cancer patients, particularly close to diagnosis.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Low Estrogen Levels May Play Role in Hypogonadism
Urology Times
Insufficient estrogen levels in men may be at least partially to blame for symptoms that are often attributed to hypogonadism, according to a recently published study. "This study establishes testosterone levels at which various physiological functions start to become impaired, which may help provide a rationale for determining which men should be treated with testosterone supplements,” said corresponding author Dr. Joel Finkelstein, of Massachusetts General Hospital, Boston.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Expulsive Therapy for Stones May Cut Costs
Renal & Urology News
Urologists may want to give patients with acute renal colic a trial of medical expulsive therapy (MET) before recommending early endoscopic stone removal (EESR), a new Canadian study suggests. Patients missed fewer days of work and were less likely to file short-term disability claims after undergoing MET than after having early endoscopic stone removal, researchers reported in a poster presentation at the the 33rd Congress of the Societé Internationale d'Urologie.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Is There a Relationship Between Severity of Coronary Artery Disease and Severity of Erectile Dysfunction?
MD Linx
Authors evaluated the association between the number of occluded coronary arteries in myocardial infarction (MI) patients with the severity of ED, and investigated the influence of related risk factors in this study group. The severity of ED correlated with the number of occluded vessels documented by coronary angiography, in male patients with acute myocardial infarction. In addition, the presence of hypertension had a significant influence over erectile function only in patients with three–vessel occlusion.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


LATEST NEWS


Detection Bias Could Explain Bladder Cancer Risk in Diabetics
Renal & Urology News
Early detection bias may explain the pattern of increased bladder cancer risk previously reported in patients with Type 2 diabetes, according to a study published online in Diabetes Care. During annual time windows following the index date, the incidence rates and hazard ratios for bladder cancer were calculated.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


3 of 4 Cases of Bladder Cancer Display Mutations in the Same Gene
Science Daily
Researchers from the Spanish National Cancer Research Centre (CNIO) have discovered that more than 70 percent of bladder tumours display somatic mutations in the TERT gene (telomerase reverse transcriptase). The TERT gene is involved in the protection of DNA and in cellular ageing processes and cancer. These results make this gene the most mutated in these tumours, which represent a serious public health problem in Spain, where the highest rates in the world are registered with 11,200 new cases each year.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


High-Risk Prostate Tumors Not All the Same
Renal & Urology News
Prostate cancer (PCa) patients who have biopsy Gleason scores of 8, 9, or 10 are lumped together as having “high-risk” disease, but they represent individual subgroups with different long-term oncologic outcomes, according to a study by the European Multicenter Prostate Cancer Clinical and Translational research group. In particular, Gleason 8 tumors are associated with a substantially better prognosis after radical prostatectomy (RP) than Gleason 9 and 10 tumors.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Lift Device For BPH Earns FDA Approval
Urology Times
The FDA authorized the marketing of the UroLift system, the first permanent implant to relieve low or blocked urine flow in men aged 50 years and older with BPH. The UroLift system, manufactured by NeoTract Inc. of Pleasanton, Calif., involves the insertion of permanent implants into the prostate to retract the lobes away from the prostatic urethra.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 

WSAUA Insights
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Andrew Plock, Content Editor, 469.420.2609  
Contribute news

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the Western Section AUA Insights was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Sept. 20, 2013
Sept. 19, 2013
Sept., 12, 2013
Sept. 5, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063